World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
49
Citations
12049
World Ranking
17889
National Ranking
7321

Overview

J. Brooks Jackson is affiliated with the University of Iowa Hospitals and Clinics in the United States. Their research contributions primarily focus on the field of Medicine, with a significant number of publications in Infectious Diseases, Epidemiology, Public Health, Environmental and Occupational Health, Obstetrics and Gynecology, and Surgery.

The scientist has worked extensively on topics including COVID-19 Clinical Research Studies, Hepatitis B Virus Studies, SARS-CoV-2 and COVID-19 Research, Cervical Cancer and HPV Research, Pelvic floor disorders treatments, COVID-19 Impact on Reproduction, and Tuberculosis Research and Epidemiology.

The following are some of their recent papers along with the year of publication and venue:

  • Human Papillomavirus and Associated Cancers: A Review, 2024, Viruses
  • Prevalence of pelvic floor disorders in adult women being seen in a primary care setting and associated risk factors, 2022, Scientific Reports
  • Head-to-Head Comparison of Two SARS-CoV-2 Serology Assays, 2020, The Journal of Applied Laboratory Medicine
  • COVID-19 convalescent plasma: phase 2, 2020, Transfusion
  • SARS-CoV-2 Infection during Pregnancy in a Rural Midwest All-delivery Cohort and Associated Maternal and Neonatal Outcomes, 2021, American Journal of Perinatology

J. Brooks Jackson frequently collaborates with several co-authors. These include Linder Wendt, Mary B. Rysavy, Kimberly A. Kenne, Anna E. Merrill, and JaNiese E. Jensen.

The scientist's work is often published in venues such as:

  • Journal of Medical - Clinical Research & Reviews
  • Microbiology & Infectious Diseases
  • Transfusion
  • American Journal of Perinatology
  • PLoS ONE

Best Publications

  • Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial

    Laura A Guay;Philippa Musoke;Thomas Fleming;Danstan Bagenda

  • Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial

    J. Brooks Jackson;Philippa Musoke;Thomas Fleming;Thomas Fleming;Laura A. Guay

  • The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter

    David A. Katzenstein;Scott M. Hammer;Michael D. Hughes;Holly Gundacker

  • Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).

    Susan H. Eshleman;Martin Mracna;Laura A. Guay;Martina Deseyve

  • Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection

    Craig W. Hendrix;Ann C. Collier;Michael Marcel Lederman;Dominique Schols

  • Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa

    Elliot Marseille;James G Kahn;Francis Mmiro;Laura Guay

  • Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials.

    Six Week Extended-Dose Nevirapine (Swen) Study Team;Abubaker Bedri;Berhanu Gudetta;Abdulhamid Isehak

  • Sensitive Drug-Resistance Assays Reveal Long-Term Persistence of HIV-1 Variants with the K103N Nevirapine (NVP) Resistance Mutation in Some Women and Infants after the Administration of Single-Dose NVP: HIVNET 012

    Tamara Flys;Dwight V. Nissley;Cassidy W. Claasen;Dana Jones

  • A phase I / II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006).

    Philippa Musoke;Laura A. Guay;Danstan Bagenda;Mark Mirochnick

  • Nevirapine (NVP) Resistance in Women with HIV-1 Subtype C, Compared with Subtypes A and D, after the Administration of Single-Dose NVP

    Susan H. Eshleman;Donald R. Hoover;Shu Chen;Sarah E. Hudelson

  • Coreceptor Tropism in Human Immunodeficiency Virus Type 1 Subtype D: High Prevalence of CXCR4 Tropism and Heterogeneous Composition of Viral Populations

    Wei Huang;Susan H. Eshleman;Jonathan Toma;Signe Fransen

  • Multicenter Evaluation of Use of Dried Blood and Plasma Spot Specimens in Quantitative Assays for Human Immunodeficiency Virus RNA: Measurement, Precision, and RNA Stability

    Don Brambilla;Cheryl Jennings;Grace Aldrovandi;James Bremer

  • Antenatal Vitamin A Supplementation Increases Birth Weight and Decreases Anemia among Infants Born to Human Immunodeficiency Virus-Infected Women in Malawi

    Newton Kumwenda;Paolo G. Miotti;Taha E. Taha;Robin Broadhead

  • Diagnostic utility of telomere length testing in a hospital-based setting

    Jonathan K. Alder;Vidya Sagar Hanumanthu;Margaret A. Strong;Amy E. DeZern

  • Absence of HIV infection in blood donors with indeterminate western blot tests for antibody to HIV-1.

    J. Brooks Jackson;Kristine L. Macdonald;Jane Cadwell;Carolyn Sullivan

  • Multicenter Evaluation Of Quantification Methods For Plasma Human Immunodeficiency Virus Type 1 Rna

    Hsiang Ju Lin;Lawrence E. Myers;Belinda Yen-Lieberman;F. Blaine Hollinger

  • Characterization of nevirapine resistance mutations in women with subtype A vs. D HIV-1 6-8 weeks after single-dose nevirapine (HIVNET 012).

    Susan H. Eshleman;Laura A. Guay;Anthony Mwatha;Elizabeth R. Brown

  • Resistance after single-dose nevirapine prophylaxis emerges in a high proportion of Malawian newborns.

    Susan H. Eshleman;Donald R. Hoover;Shu Chen;Sarah E. Hudelson

  • Impact of Human Immunodeficiency Virus Type 1 (HIV-1) Subtype on Women Receiving Single-Dose Nevirapine Prophylaxis to Prevent HIV-1 Vertical Transmission (HIV Network for Prevention Trials 012 Study)

    Susan H. Eshleman;Graziella Becker-Pergola;Martina Deseyve;Laura A. Guay

  • Persistence of nevirapine exposure during the postpartum period after intrapartum single-dose nevirapine in addition to zidovudine prophylaxis for the prevention of mother-to-child transmission of HIV-1.

    Tim R. Cressey;Gonzague Jourdain;Marc J. Lallemant;Suparat Kunkeaw

Frequent Co-Authors

Susan H. Eshleman
Susan H. Eshleman Johns Hopkins University School of Medicine
Mary Glenn Fowler
Mary Glenn Fowler Johns Hopkins University
Deborah Donnell
Deborah Donnell Fred Hutchinson Cancer Research Center
Susan A. Fiscus
Susan A. Fiscus University of North Carolina at Chapel Hill
Taha E. Taha
Taha E. Taha Johns Hopkins University
Saad B. Omer
Saad B. Omer The University of Texas Southwestern Medical Center
Donald R. Hoover
Donald R. Hoover Rutgers, The State University of New Jersey
Lynne M. Mofenson
Lynne M. Mofenson Elizabeth Glaser Pediatric AIDS Foundation
Henry H. Balfour
Henry H. Balfour University of Minnesota
Neil Parkin
Neil Parkin Data First COnsulting

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Aspiring professionals in Biology and Biochemistry have a variety of online degree opportunities to expand their career options. Many students pursue healthcare administration roles by enrolling in online mha programs cahme accredited, which ensure a rigorous and industry-respected curriculum. These programs are ideal for those interested in leadership within hospitals, clinics, and research institutions.

For nurses aiming to advance without traditional clinical components, there are flexible options like a dnp program without clinical hours. This pathway is especially suited to those focusing on leadership, policy, or educational roles in healthcare.

Graduate-level study also includes online doctoral programs such as the phd in healthcare management online, perfect for those who wish to enter academic, executive, or research positions in health services.

For students motivated by pharmaceutical sciences, pursuing an online pharmd offers the chance to become a licensed pharmacist or progress into regulatory, consulting, or academic fields. These online degrees open doors for biologists and biochemists to transition into specialized healthcare careers or leadership roles.

Best Scientists Citing J. Brooks Jackson

Trending Scientists

Recently Published Articles